USPTO serial 77438607
AOBO AMERICAN ORIENTAL BIOENGINEERING INC
Reviewed by CopyMark Law Group
Reg. 3662543Status 710
- Filing date
- Status date
- Registration date
- Aug 4, 2009
- Examiner
- CRAWFORD, MARY
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with AOBO AMERICAN ORIENTAL BIOENGINEERING INC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
AMERICAN ORIENTAL BIOENGINEERING INC
NEW YORK, NY
Other trademarks owned by AMERICAN ORIENTAL BIOENGINEERING INC
AMERICAN ORIENTAL BIOENGINEERING INC
NEW YORK, NY
Other trademarks owned by AMERICAN ORIENTAL BIOENGINEERING INC
AMERICAN ORIENTAL BIOENGINEERING INC
NEW YORK, NY
Other trademarks owned by AMERICAN ORIENTAL BIOENGINEERING INC
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines for human purposes for use in gynecology; medicines for human purposes for treating colds and fever; Chinese medicine nostrums, namely, Chinese traditional medicines in the form of medicinal antibiotic, anti-inflammatory, anti-itch, anti-pain and mentholated ointments and oils for use in the treatment of the digestive system, respiratory system, immune system, circulatory system, female reproductive system, nervous system, rheumatism, inflammation of the nasal mucous membrane caused by colds, and for relief of pain caused by sprains and strains and medicinal teas, ginseng for medicinal use and medicinal herbal extracts for medical purposes; disinfectants for hygienic purposes; pills for pharmaceutical purposes, in the treatment of cold, headache, sleeping problem, poor blood circulation; albuminous milk, for medical purposes; dietetic foods adapted for medical use; biometallic compounds for consumption and/or injection for use in medical imaging and for diagnostic purposes; diagnostic preparations for medical purposes; vaginal washes; medicinal herbs; biological preparations for medical purposes; medicine made from plants for the treatment of the digestive system, respiratory system, immune system, circulatory system, female reproductive system, nervous system; pharmaceutical preparations, namely, anti-uric preparations for use in the treatment of enuresis; medicinal oils, namely, medicated oils for use in the relief of rheumatism, relief of inflammation of the nasal mucous membrane caused by colds, and for relief of pain caused by sprains and strains; suppositories; medicated confectionery; tissues impregnated with pharmaceutical lotions, namely, pharmaceutical skin lotions; medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; medicinal drinks; pharmaceutical preparations for use in chemotherapy; herbal supplements; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical antitussive-cold preparations; pharmaceutical anti-allergic preparations and substances; anticoagulants; antidepressants; appetite suppressants; pharmaceutical preparation for the treatment of gout; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for wounds; pharmaceutical preparations for use in urology; pharmaceutical products and preparations for preventing skin blemishes during pregnancy; raw medicines for use in the treatment of skin disorders, heart conditions; gynecological products, namely, medicinally treated sanitary towels and the medicines used to support the health of the circulatory and female-reproductive system; traditional Chinese medicines, namely, Chinese patent medicines for use in the treatment of colds, medicated balms, namely, medicated lip balms, medicinal oils, namely, medicated baby oil, capsules for medicines, namely, unit dose capsules sold empty for pharmaceutical use, medicinal teas, ginseng for medical use, nutritional supplement, namely, swallow-nests, herbal medicine for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, namely, medical herbal extracts for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; herbal teas for medicinal purposes; herbal medicines for medical purposes, namely, medicinal herbal extracts for medical purposes; biological preparations for medical purposes; milk for medical purposes; vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use | SECTION 8 - CANCELLED | Mar 30, 2006 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by AMERICAN ORIENTAL BIOENGINEERING INC
- Other trademarks owned by AMERICAN ORIENTAL BIOENGINEERING INC
- Other trademarks owned by AMERICAN ORIENTAL BIOENGINEERING INC
- Other trademarks in Class 005
- Similar marks named AOBO AMERICAN ORIENTAL BIOENGINEERING INC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 11, 2016 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Aug 22, 2010 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 22, 2010 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 4, 2009 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 19, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 29, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Apr 15, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 14, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 24, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 24, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 24, 2009 | ALIE | ASSIGNED TO LIE | — |
| Mar 23, 2009 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Mar 23, 2009 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 23, 2009 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 12, 2009 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 12, 2009 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 12, 2009 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 3, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 3, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 3, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 18, 2008 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 18, 2008 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 18, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 15, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 8, 2008 | MDSC | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| Apr 7, 2008 | NWAP | NEW APPLICATION ENTERED | — |